Medipattern Featured on WABC Radio Programs
October 03 2011 - 9:00AM
Marketwired
Attention: Business/Financial Editors
The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a
pioneer in the development of medical imaging software solutions
that help medical practitioners to better understand lesions and
critical anatomy, announced today that the Company will be featured
on a Corporate Profile Minute heard on the nationally syndicated
"Larry Kudlow Show", which airs Saturday mornings from 10:00 am to
1:00 pm EST on WABC Radio (AM770). The show offers listeners a
tremendous wealth of insight and expertise to help better navigate
today's evolving economic, investing, and political terrain.
In addition, Medipattern Corporation president and CEO, Jeff
Collins, and Francis Porreca MD, FACS, RPVI, Director of the Weiler
Division of Vascular Surgery at Montefiore Medical Center, will be
interviewed on the Money on the Mark program hosted by Dale
Jackson. The program can be downloaded from www.medipattern.com as
aired on WMCA radio in New York on October 1st. In an excerpt from
the interview, Dr. Porreca describes the problems caused by stroke
as well as methods to identify at-risk patients to reduce the
incidence of stroke in the at-risk population:
"Stroke is a tremendous problem in our country: 700,000 strokes
occur annually and 165,000 deaths. It is the third leading cause of
death after heart and cancer related causes. It is responsible for
significant disability and loss of productivity especially for
those who survive. Obviously it has tremendous health cost
implications," comments Dr. Porreca. "Visualize has had a huge
impact on our practice as vascular surgeons and we use it every
day. Presently there are four tests that are used to look for
obstructions in carotid arteries. (The first three tests, CTA, MRA,
conventional angiography) all have inherent problems. They are
invasive. They are expensive and they are associated with some
toxicity because they require the administration of contract
agents. The (fourth method) is the gold standard, the carotid
duplex study, which is a combination of ultrasound and Doppler to
give hemodynamic information. This also has some inherent problems;
with ultrasound alone we are not able to precisely determine the
exact amount of obstruction in the artery. What Visualize:Vascular
has enabled us to do is to look at that artery in three dimensions
using computer aided technology. We can then determine the
reduction there is in the lumen and if there is a significant
reduction, of course, the patient would benefit from having that
artery operated on to remove the blockage in the artery which would
reduce the incidence of stroke in these patients."
2011 Upcoming Events
Veith 38th Annual Symposium, Nov. 16 to 20 with partner
Navix
RSNA 2011, Nov. 27 - Dec. 2 with partners TomTec and PenRad
About The Medipattern Corporation:
Medipattern® is a pioneer in the development of imaging software
solutions that help medical practitioners to better understand
lesions and critical anatomy. Medipattern uses its Cadenza(TM)
technology to process images, finding the salient region of
interest and presenting them in 2D and 3D formats that enhance the
reader's perception. For more information, please visit the
Company's website: www.medipattern.com.
Medipattern® is a registered mark of The Medipattern
Corporation. Visualize:Vascular(TM) is a trademark of the
Medipattern Corporation.
Forward-looking statements
This document contains forward-looking statements relating to
Medipattern's performance, operations, or business environment.
These statements are based on what we believe are reasonable
assumptions given currently available information and our
understanding of Medipattern's current activities. We have tried,
whenever possible, to identify these forward-looking statements
using words such as "anticipates," "believes," "estimates,"
"expects," "plans," "intends," "potential", and similar
expressions. Forward-looking statements are not guarantees of
future performance and involve risks and uncertainties that are
difficult to predict or control. A number of factors could cause
actual outcomes and results to differ materially from those
expressed in forward-looking statements. These factors include but
are not limited to those set forth in the Company's corporate
filings, (posted at www.sedar.com). In addition, these
forward-looking statements relate to the date on which they are
made. The Company disclaims any intention or obligation to update
or revise any forward-looking statements for any reason. Readers
should not rely on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Contacts: The Medipattern Corporation Jeff Collins CEO (416)
744-0009 ext. 224jcollins@medipattern.com Spinnaker Capital Markets
Inc. Kevin O'Connor (416) 962-3300 ext. 226ko@spinnakercmi.com
The Medipattern Corp. (TSXV:MKI)
Historical Stock Chart
From Jun 2024 to Jul 2024
The Medipattern Corp. (TSXV:MKI)
Historical Stock Chart
From Jul 2023 to Jul 2024